J. Jack Lee

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.2Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3251

Top 32%

0.613DataRank

Top 32%15 citations

Jingxin Fu, Carrie Cibulskis, Aashna Jhaveri, Curtis Gumbs, Biswajit Das +41 more

Papers

Driven by 69 papers — median percentile 47. Top paper: “Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC”.

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.04.026

N/A

6.8DataRank · unranked

195 citations

Marcelo V. Negrão, Seyedeh Dibaj, Runzhe Chen, Alexandre Reuben, Jadi M. Bohac +32 more

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Nature Medicine(2023)10.1038/s41591-022-02189-0

N/A

4.1DataRank · unranked

213 citations

Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy +52 more

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-25188-0

N/A

3.1DataRank · unranked

110 citations

Annikka Weissferdt, Myrna C. B. Godoy, William N. William, Cheuk Hong Leung, Heather Lin +23 more

New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development

Cancer Prevention Research(2015)10.1158/1940-6207.capr-14-0179

N/A

2.8DataRank · unranked

78 citations

Curtis R. Pickering, Vassiliki A. Papadimitrakopoulou, Jaroslav Jelinek, Steven H. Lin, William N. William +16 more

Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

Genome Medicine(2021)10.1186/s13073-021-00969-w

N/A

1.9DataRank · unranked

90 citations

Shumei Kato, Ryosuke Okamura, Hitendra Patel, Mina Nikanjam, Paul T. Fanta +14 more

Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment

Lung Cancer(2022)10.1016/j.lungcan.2022.08.007

N/A

0.935DataRank · unranked

23 citations

Jiexin Zhang, Erin M. Bayley, Meredith Frank, Shin‐Heng Chiou, Carmen Behrens +21 more

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002891

N/A

0.854DataRank · unranked

296 citations

Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bāra, Vincent K. Shen +33 more

Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade

Nature Communications(2022)10.1038/s41467-022-32171-w

N/A

0.813DataRank · unranked

23 citations

Orr Ashenberg, Jack Lee, Samantha J. Riesenfeld, Matan Hofree, Maria Aggelakopoulou +21 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0.787DataRank · unranked

189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3351

N/A

0.780DataRank · unranked

180 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew O. Old +21 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0.769DataRank · unranked

168 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy

Clinical Lung Cancer(2020)10.1016/j.cllc.2019.11.003

N/A

0.712DataRank · unranked

114 citations

Apar Pataer, Ara A. Vaporciyan, Arlene M. Correa, Boris Sepesi, César A. Moran +10 more

Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.12.011

N/A

0.678DataRank · unranked

91 citations

Jianjun Zhang, Carol C. Wu, Hai T. Tran, Lerong Li, Lixia Diao +13 more

Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights

Nature Communications(2024)10.1038/s41467-024-47512-0

N/A

0.672DataRank · unranked

87 citations

Muhammad Aminu, Tatiana V. Karpinets, Pingjun Chen, Maliazurina B. Saad, Morteza Salehjahromi +32 more

Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue

Scientific Reports(2021)10.1038/s41598-021-88156-0

N/A

0.639DataRank · unranked

70 citations

María C. Ferrufino‐Schmidt, Auriole Tamegnon, Jiexin Zhang, Luisa M. Solis, Mei Jiang +6 more

Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3251

Top 32%

0.613DataRank

Top 32%15 citations

Jingxin Fu, Carrie Cibulskis, Aashna Jhaveri, Curtis Gumbs, Biswajit Das +41 more

Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer

Nature Communications(2021)10.1038/s41467-021-26821-8

N/A

0.598DataRank · unranked

53 citations

Runzhe Chen, Ying Jin, Jun Li, Xin Hu, Jiexin Zhang +40 more

Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-0251

N/A

0.564DataRank · unranked

42 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101463

N/A

0.546DataRank · unranked

37 citations

Tatiana V. Karpinets, Sheeba J. Sujit, Mohamed Qayati, Pingjun Chen, Muhammad Aminu +32 more

Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma

Modern Pathology(2023)10.1016/j.modpat.2023.100326

N/A

0.533DataRank · unranked

34 citations

Frank Rojas, Xin Hu, Alejandra G. Serrano, Bo Zhu, Hong Chen +23 more

Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.06.003

N/A

0.524DataRank · unranked

32 citations

Pedro Rocha, Edwin R. Parra, Lei Feng, Jaime Rodriguez‐Canales, Luisa M. Solis +12 more

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

Cancer Cell(2025)10.1016/j.ccell.2025.04.003

N/A

0.505DataRank · unranked

28 citations

Pingjun Chen, Muhammad Aminu, Jiànróng Lǐ, Junya Fujimoto, Yanhua Tian +47 more

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.11.020

N/A

0.494DataRank · unranked

26 citations

Robyn Du, Nathaniel J. Myall, Whitney E. Lewis, Natalie Uy, Lingzhi Hong +22 more

Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0469

N/A

0.489DataRank · unranked

25 citations

Yuejiang Liu, Fuduan Peng, Sujuan Yang, Mohamed A. Jamal, Manvi Sharma +30 more

Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2023)10.1016/j.jtcvs.2023.09.073

N/A

0.477DataRank · unranked

23 citations

Boris Sepesi, Cheuk Hong Leung, Heather Lin, Annikka Weissferdt, Apar Pataer +15 more

Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection

Annals of Surgical Oncology(2021)10.1245/s10434-021-10291-9

N/A

0.470DataRank · unranked

22 citations

Sandra R. DiBrito, J. Jack Lee, Abigail S. Caudle, Mark W. Clemens, Vijaya Gottumukkala +6 more

Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy

Modern Pathology(2023)10.1016/j.modpat.2023.100353

N/A

0.470DataRank · unranked

22 citations

Cheuk Hong Leung, Heather Lin, Boris Sepesi, William N. William, Stephen G. Swisher +4 more

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer

Lung Cancer(2020)10.1016/j.lungcan.2020.08.023

N/A

0.457DataRank · unranked

20 citations

Lingzhi Hong, Monique B. Nilsson, Shawna M. Hubert, Shuhong Wu, Waree Rinsurongkawong +11 more

LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence

The Annals of Thoracic Surgery(2020)10.1016/j.athoracsur.2020.03.114

N/A

0.442DataRank · unranked

18 citations

Edwin R. Parra, Jiexin Zhang, David B. Nelson, Erin M. Corsini, Pamela Villalobos +22 more

SwarmDeepSurv: swarm intelligence advances deep survival network for prognostic radiomics signatures in four solid cancers

Patterns(2023)10.1016/j.patter.2023.100777

N/A

0.416DataRank · unranked

15 citations

Maliazurina B. Saad, Ajay Sheshadri, Carol C. Wu, Joe Y. Chang, Bissan Al‐Lazikani +9 more

Spatial PD‐L1, immune‐cell microenvironment, and genomic copy‐number alteration patterns and drivers of invasive‐disease transition in prospective oral precancer cohort

Cancer(2023)10.1002/cncr.34607

N/A

0.406DataRank · unranked

14 citations

Jianjun Zhang, Xin Zhao, Edwin R. Parra, Naohiro Uraoka, Heather Lin +16 more

Depletion of Effector Regulatory T Cells Associates with Major Response to Induction Dual Immune Checkpoint Blockade

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1390

N/A

0.406DataRank · unranked

14 citations

Nils-Petter Rudqvist, Bo Jiang, Shengbin Ye, Shan He, Qingnan Liang +26 more

Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis

Otolaryngology(2024)10.1002/ohn.672

N/A

0.385DataRank · unranked

12 citations

Amy C. Moreno, Yun Qing, J. Jack Lee, Faye M. Johnson, Miriam N. Lango +10 more

Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19

Cancers(2022)10.3390/cancers15010275

N/A

0.373DataRank · unranked

11 citations

Divya Yadav, Lingzhi Hong, Elliana Young, Paul Edelkamp, Maliazurina B. Saad +23 more

Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.07.121

N/A

0.373DataRank · unranked

11 citations

Alessandro Di Federico, Bolun Liu, Alissa J. Cooper, Joao V. Alessi, Phoebe Clark +25 more

Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation

Cancer(2021)10.1002/cncr.33491

N/A

0.360DataRank · unranked

10 citations

Faiez Saiyed, Christopher M. K. L. Yao, Kimberley L. Kiong, Julian Martinez, Ruth Sacks +10 more

Impact of genomic aberrations and additional therapies on survival outcomes of patients with operable non-small cell lung cancer (NSCLC) from the NEOSTAR study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8542

Top 49%

0.359DataRank

Top 49%3 citations

Boris Sepesi, Cheuk Hong Leung, Heather Lin, William Nassib William, Annikka Weissferdt +15 more

Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events

Frontiers in Immunology(2023)10.3389/fimmu.2023.1322818

N/A

0.357DataRank · unranked

6 citations

Quan‐Zhen Li, Qi Wang, Natalie I. Vokes, Ajay Sheshadri, Jianjun Gao +14 more

First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1735

N/A

0.345DataRank · unranked

9 citations

Hui Li, Alessandro Di Federico, Jia Wu, Hong Chen, Eleonora Gariazzo +26 more

The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial

Advances in Radiation Oncology(2020)10.1016/j.adro.2020.100635

N/A

0.330DataRank · unranked

8 citations

J. Jack Lee, Beow Y. Yeap, Rong Ye, Robert L. Foote, Paul M. Busse +15 more

Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2290

N/A

0.330DataRank · unranked

8 citations

Madison P. O’Hara, Laçin Yapindi, Peixin Jiang, Hai T. Tran, Alexandre Reuben +8 more

Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC

Nature Communications(2025)10.1038/s41467-025-61823-w

N/A

0.312DataRank · unranked

7 citations

Qasem Al-Tashi, Lingzhi Hong, Vivek Verma, Wentao Li, Daniel Boiarsky +32 more

Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0179

N/A

0.292DataRank · unranked

6 citations

J. Jack Lee, Yu‐Hung Wu, Xi Liu, Masanori Kawakami, Jonathan M. Kurie +7 more

Glycemic control in diabetic patients improved overall lung cancer survival across diverse populations

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae081

Top 57%

0.277DataRank

Top 57%4 citations

Brian T. Luke, Xiao-Cheng Wu, J. Jack Lee, Yong Yi, Samuel C. Okpechi +7 more

CIMAC-CIDC tissue imaging harmonization.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3125

N/A

0.269DataRank · unranked

5 citations

Edwin R. Parra, Ana Lako, Evisa Gjini, Beatriz Sánchez Espiridión, Ignacio I. Wistuba +10 more

Phase I study of hydroxychloroquine plus binimetinib in patients with metastatic pancreatic cancer (the HOPE trial).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps634

N/A

0.269DataRank · unranked

5 citations

J. Jack Lee, Brandon G. Smaglo, Dan Zhao, Michael Sangmin Lee, Robert A. Wolff +5 more

Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011760

N/A

0.245DataRank · unranked

4 citations

Jillian Fisher, Young Kwang Chae, Luisa M. Solis Soto, Anup Kasi, Bhavana Konda +27 more

Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013074

N/A

0.241DataRank · unranked

4 citations

Eman Showkatian, Vivek Verma, Qasem Al-Tashi, Muhammad Aminu, Xinyan Xu +17 more

Joint multi-omics discriminant analysis with consistent representation learning using PANDA

Research Square(2024)10.21203/rs.3.rs-4353037/v1

N/A

0.217DataRank · unranked

2 citations

Muhammad Aminu, Lingzhi Hong, Natalie I. Vokes, Stephanie Schmidt, Maliazurina B. Saad +15 more

A randomized presurgical trial of alternative dosing of exemestane in postmenopausal women with early-stage ER-positive breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.519

N/A

0.165DataRank · unranked

2 citations

Davide Serrano, Sara Gandini, Parijatham S. Thomas, Katherine D. Crew, Nagi B. Kumar +15 more

Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients

Cancers(2025)10.3390/cancers17213406

N/A

0.104DataRank · unranked

1 citations

Hui Li, Eman Showkatian, Maliazurina B. Saad, Mohamed Qayati, Sohair Ismail +25 more

Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates

Nature Communications(2025)10.1038/s41467-025-63718-2

N/A

0DataRank · unranked

37 citations

Brandon G. Smaglo, Krishnan K. Mahadevan, Michelle L. Kirtley, Kathleen M. McAndrews, Mayela Carolina Mendt +19 more

Chemotherapy alone for stage II–IVa laryngeal squamous cell carcinoma: A 20‐year follow‐up

Cancer(2025)10.1002/cncr.70177

N/A

0DataRank · unranked

1 citations

Matheus Sewastjanow‐Silva, F. Christopher Holsinger, Adam S. Garden, Adel K. El‐Naggar, Jeffrey N. Myers +7 more

Multiomics profiling and association with molecular and immune features in association with benefits from immunotherapy for patients with previously treated stage IV or recurrent squamous cell lung cancer from the phase III SWOG LungMAP S1400I trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9046

N/A

0DataRank · unranked

0 citations

Dzifa Y. Duose, Jiexin Zhang, Mary W. Redman, Rossana Lazcano Segura, Mario L. Marques‐Piubelli +14 more

Phase I study of mesenchymal stem cell (MSC)-derived exosomes with KRASG12D siRNA in patients with metastatic pancreatic cancer harboring a KRASG12D mutation.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps633

N/A

0DataRank · unranked

39 citations

Valerie S. LeBleu, J. Jack Lee, Brandon G. Smaglo, Dan Zhao, Michael Sangmin Lee +11 more

Robust and Efficient Assessment of Potency (REAP): A Quantitative Tool for Dose-response Curve Estimation

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.20.469388

N/A

0DataRank · unranked

0 citations

Xinyi Liu, Xinying Fang, Vernon M. Chinchilli, Michael Wang, Honggang Wang +4 more

Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.13819

N/A

0DataRank · unranked

12 citations

Joseph Abi Jaoude, Roshal R. Patel, Ramez Kouzy, Timothy A. Lin, Brian De +11 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305.v1

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

Data from Phase I Oncology Studies: Evidence That in the Era of Targeted Therapies Patients on Lower Doses Do Not Fare Worse

(2023)10.1158/1078-0432.c.6519332.v1

N/A

0DataRank · unranked

0 citations

J. Jack Lee, David S. Hong, Maurie Markman, Jing Gong, Aung Naing +3 more

Data from Phase I Oncology Studies: Evidence That in the Era of Targeted Therapies Patients on Lower Doses Do Not Fare Worse

(2023)10.1158/1078-0432.c.6519332

N/A

0DataRank · unranked

0 citations

J. Jack Lee, David S. Hong, Maurie Markman, Jing Gong, Aung Naing +3 more

REAP-2: An interactive quantitative tool for robust and efficient dose-response curve estimation

Journal of Clinical and Translational Science(2023)10.1017/cts.2023.642

N/A

0DataRank · unranked

0 citations

Xinyi Liu, Vernon M. Chinchilli, Michael Wang, Honggang Wang, Nikolay V. Dokholyan +4 more

Genomic and TCR Repertoire Intratumor Heterogeneity of Small-cell Lung Cancer and its Impact on Survival

Research Square(2021)10.21203/rs.3.rs-148314/v1

N/A

0DataRank · unranked

0 citations

Runzhe Chen, Ying Jin, Jun Li, Jiexin Zhang, Junya Fujimoto +36 more

The use of local and nonlocal priors in Bayesian test‐based monitoring for single‐arm phase II clinical trials

Pharmaceutical Statistics(2021)10.1002/pst.2139

N/A

0DataRank · unranked

4 citations

Ruitao Lin, J. Jack Lee, Yanhong Zhou

The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1

Cancer Cell(2021)10.1016/j.ccell.2021.11.002

N/A

0DataRank · unranked

310 citations

Yi Xiao, Qin Li, Jun Yao, Xiangliang Yuan, Yuan Zhang +15 more

Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0566

N/A

0DataRank · unranked

13 citations

Zachary R. McCaw, Alex Koong, Christine Lin, Joseph Abi Jaoude, Roshal R. Patel +14 more

Genomic and TCR Repertoire Intratumor Heterogeneity of Small-cell Lung Cancer and its Impact on Survival

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.30.180844

N/A

0DataRank · unranked

0 citations

Runzhe Chen, Ying Jin, Jun Li, Jiexin Zhang, Junya Fujimoto +32 more

Data from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

(2024)10.1158/1078-0432.c.7181344.v1

Top 100%

0DataRank

Top 100%0 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

REDOMA: Bayesian random‐effects dose‐optimization meta‐analysis using spike‐and‐slab priors

Statistics in Medicine(2024)10.1002/sim.10107

N/A

0DataRank · unranked

0 citations

Evan Kwiatkowski, J. Jack Lee, Ruitao Lin, Cheng‐Han Yang

J. Jack Lee

Indexed papers

Top data-sharing exemplar

Papers